Literature DB >> 5822902

Rifampicin and poxvirus replication.

Z Ben-Ishai, E Heller, N Goldblum, Y Becker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5822902     DOI: 10.1038/224029a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  21 in total

1.  Antiviral action of a rifamycin derivative: formation Rous sarcoma virus particles deficient in 60 to 70S RNA.

Authors:  C Szabo; M J Bissell
Journal:  J Virol       Date:  1978-03       Impact factor: 5.103

2.  The inhibition of variola minor virus multiplication by rifampicin.

Authors:  T H Pennington
Journal:  Arch Gesamte Virusforsch       Date:  1970

3.  Inhibition of poxvirus maturation by rifamycin derivatives and related compounds.

Authors:  T H Pennington; E A Follett
Journal:  J Virol       Date:  1971-06       Impact factor: 5.103

4.  Rifamycins: modulation of specific anti-poxviral activity by small substitutions on the piperazinyliminomethyl side chain.

Authors:  B Moss; E N Rosenblum; P M Grimley; S J Mims
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

5.  Failure of rifampin to inhibit adenovirus replication.

Authors:  D P McCormick; R P Wenzel; E P Smith; W E Beam
Journal:  Antimicrob Agents Chemother       Date:  1972-10       Impact factor: 5.191

6.  Inhibition of Poxvirus replication by streptovaricin.

Authors:  N A Quintrell; B R McAuslan
Journal:  J Virol       Date:  1970-10       Impact factor: 5.103

7.  Ribonucleic acid polymerase induced by vaccinia virus: lack of inhibition by rifampicin and alpha-amanitin.

Authors:  F Costanzo; L Fiume; M La Placa; A Mannini-Palenzona; F Novello; F Stirpe
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

8.  Effect of rifamycins and related antibiotics on the deoxyribonucleic acid-dependent ribonucleic acid polymerase of vaccinia virus particles.

Authors:  J F Szilágyi; T H Pennington
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

9.  Inhibition of infectious Rous sarcoma virus production by rifamycin derivative.

Authors:  C Szabo; M J Bissell; M Calvin
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

10.  Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).

Authors:  G Medoff; G S Kobayashi; C N Kwan; D Schlessinger; P Venkov
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.